ALZHEIMER'S DRUG DISCOVERY FOUNDATION
Data sourced from IRS 990 public filings
ALZHEIMER'S DRUG DISCOVERY FOUNDATION ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT AND TREAT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.
Annual Revenue
$47,282,987
Known Funders
236
Grants Received
470
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $47,282,987 | $88,250,427 | $299,394,693 |
| 2023 | $37,742,020 | $61,943,588 | $324,173,528 |
| 2022 | $254,027,105 | $36,842,901 | $340,253,841 |
| 2021 | $53,037,104 | $37,126,176 | $116,420,075 |
| 2020 | $27,631,350 | $28,251,909 | $97,381,722 |
| 2019 | $22,712,391 | $32,429,304 | $97,175,562 |
| 2018 | $55,817,240 | $16,190,686 | $90,038,223 |
| 2017 | $14,478,811 | $17,762,480 | $45,973,409 |
Top Funders
Pasadena, CA
Pasadena, CA
MARIETTA, GA
Pasadena, CA
Pasadena, CA
NOVATO, CA
SHREVEPORT, LA
KING OF PRUSSIA, PA
Showing top 10 of 236 funders.
Key Personnel
From 2024 IRS 990 filing
LAURA NISENBAUM
EXECUTIVE DIRECTOR, DRUG DEVELOPMENT
LAKITA CAVIN
ATTORNEY, MISSION-RELATED
JANE MCINTOSH
CHIEF EXTERNAL AFFAIRS
ELI SHOBIN
SENIOR DIRECTOR DXA
AARON BURSTEIN
HEAD OF SEARCH AND EVALUATION
MARK ROITHMAYR
CEO
KAREN HARRIS
CFO AND HEAD OF MISSION RELATED INV
THOMAS SMITH JR
GOVERNOR
THOMAS MCWILLIAMS
CO-VICE CHAIRMAN & TREASURER
SHARON SAGER
GOVERNOR
Showing 10 of 37 key personnel.
Frequently Asked Questions
Other Nonprofits in New York
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.